Autologous adipose-derived mesenchymal stromal cells (Mayo Clinic)

N/A

Report date: 2022/11/27 19:39:08

Base Information

Drug NameAutologous adipose-derived mesenchymal stromal cells (Mayo Clinic)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMayo Clinic

China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic

Inactive CompaniesN/A

Active IndicationsAmyotrophic Lateral Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A